CRMLW
Critical Metals Corp.
Industrial Materials
Market Cap$437M
5Y Perf.+5354.5%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CRMLW vs CRIS
Revenue, margins, valuation, and 5-year total return — side by side.
CRIS
Curis, Inc.
Biotechnology
Market Cap$76M
5Y Perf.-94.3%
CRMLW vs CRIS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CRMLW | CRIS |
|---|---|---|
| Industry | Industrial Materials | Biotechnology |
| Market Cap | $437M | $76M |
| Revenue (TTM) | — | $9M |
| Net Income (TTM) | $-147M | $-8M |
| Gross Margin | — | 99.5% |
| Operating Margin | — | -348.4% |
| Total Debt | $19M | $2M |
| Cash & Equiv. | $1M | $5M |
CRMLW vs CRIS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CRMLW
CRIS
| Stock | Feb 24 | May 26 | Return |
|---|---|---|---|
| Critical Metals Cor… (CRMLW) | 100 | 5454.5 | +5354.5% |
| Curis, Inc. (CRIS) | 100 | 5.7 | -94.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRMLW vs CRIS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: CRMLW and CRIS are tied at the top with 2 categories each — the right choice depends on your priorities. Curis, Inc. is the stronger pick specifically for capital preservation and lower volatility and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CRMLW
Critical Metals Corp.
The Long-Run Compounder
CRMLW has the current edge in this matchup, primarily because of its strength in long-term compounding.
- 42.3% 10Y total return vs CRIS's -99.7%
- -61.8% margin vs CRIS's -80.3%
- +23.5% vs CRIS's -72.0%
Best for: long-term compounding
CRIS
Curis, Inc.
The Income Pick
CRIS is the clearest fit if your priority is income & stability and growth exposure.
- beta 1.87
- Rev growth -13.4%, EPS growth 91.6%, 3Y rev CAGR -2.4%
- Lower volatility, beta 1.87, Low D/E 29.6%, current ratio 0.36x
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Quality / Margins | CRMLW | -61.8% margin vs CRIS's -80.3% |
| Stability / Safety | CRIS | Beta 1.87 vs CRMLW's 2.96 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | CRMLW | +23.5% vs CRIS's -72.0% |
| Efficiency (ROA) | CRIS | -26.1% ROA vs CRMLW's -312.7% |
CRMLW vs CRIS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
CRMLW vs CRIS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCRMLWLAGGINGCRIS
CRISCuris, Inc.
1leads
CRMLWCritical Metals Corp.
2leads
6 Total Categories
CATEGORYLEADERvs CRISMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
—
—
Valuation MetricsMultiples, price ratios, and targets
CRMLW1/1
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
CRIS5/7
Total Returns1Y, 3Y, 5Y total returns with dividends
CRMLW6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
Insufficient data to determine a leader in this category.
Income & Cash Flow (Last 12 Months)
| Metric | CRMLWCritical Metals C… | CRISCuris, Inc. |
|---|---|---|
| RevenueTrailing 12 months | — | $9M |
| EBITDAEarnings before interest/tax | — | -$33M |
| Net IncomeAfter-tax profit | — | -$8M |
| Free Cash FlowCash after capex | — | -$27M |
| Gross MarginGross profit ÷ Revenue | — | +99.5% |
| Operating MarginEBIT ÷ Revenue | — | -3.5% |
| Net MarginNet income ÷ Revenue | — | -80.3% |
| FCF MarginFCF ÷ Revenue | — | -2.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -66.0% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +198.4% |
Insufficient data to determine a leader in this category.
Valuation Metrics
CRMLW leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | CRMLWCritical Metals C… | CRISCuris, Inc. |
|---|---|---|
| Market CapShares × price | $437M | $76M |
| Enterprise ValueMkt cap + debt − cash | $455M | $73M |
| Trailing P/EPrice ÷ TTM EPS | -2.97x | -0.99x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 8.04x |
| Price / BookPrice ÷ Book value/share | — | 13.91x |
| Price / FCFMarket cap ÷ FCF | — | — |
CRMLW leads this category, winning 1 of 1 comparable metric.
Profitability & Efficiency
CRIS leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
CRIS delivers a -138.8% return on equity — every $100 of shareholder capital generates $-139 in annual profit, vs $-23 for CRMLW. On the Piotroski fundamental quality scale (0–9), CRIS scores 3/9 vs CRMLW's 1/9, reflecting mixed financial health.
| Metric | CRMLWCritical Metals C… | CRISCuris, Inc. |
|---|---|---|
| ROE (TTM)Return on equity | -23.3% | -138.8% |
| ROA (TTM)Return on assets | -3.1% | -26.1% |
| ROICReturn on invested capital | -14.6% | — |
| ROCEReturn on capital employed | -21.7% | -2.3% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 3 |
| Debt / EquityFinancial leverage | — | 0.30x |
| Net DebtTotal debt minus cash | $18M | -$3M |
| Cash & Equiv.Liquid assets | $1M | $5M |
| Total DebtShort + long-term debt | $19M | $2M |
| Interest CoverageEBIT ÷ Interest expense | -0.08x | -107.35x |
CRIS leads this category, winning 5 of 7 comparable metrics.
Total Returns (Dividends Reinvested)
CRMLW leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRMLW five years ago would be worth $432,693 today (with dividends reinvested), compared to $28 for CRIS. Over the past 12 months, CRMLW leads with a +2353.4% total return vs CRIS's -72.0%. The 3-year compound annual growth rate (CAGR) favors CRMLW at 2.5% vs CRIS's -67.0% — a key indicator of consistent wealth creation.
| Metric | CRMLWCritical Metals C… | CRISCuris, Inc. |
|---|---|---|
| YTD ReturnYear-to-date | +97.8% | -41.1% |
| 1-Year ReturnPast 12 months | +2353.4% | -72.0% |
| 3-Year ReturnCumulative with dividends | +4226.9% | -96.4% |
| 5-Year ReturnCumulative with dividends | +4226.9% | -99.7% |
| 10-Year ReturnCumulative with dividends | +4226.9% | -99.7% |
| CAGR (3Y)Annualised 3-year return | +2.5% | -67.0% |
CRMLW leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — CRMLW and CRIS each lead in 1 of 2 comparable metrics.
Risk & Volatility
CRIS is the less volatile stock with a 1.87 beta — it tends to amplify market swings less than CRMLW's 2.96 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CRMLW currently trades 26.0% from its 52-week high vs CRIS's 18.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CRMLWCritical Metals C… | CRISCuris, Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.96x | 1.87x |
| 52-Week HighHighest price in past year | $20.73 | $3.13 |
| 52-Week LowLowest price in past year | $0.17 | $0.49 |
| % of 52W HighCurrent price vs 52-week peak | +26.0% | +18.4% |
| RSI (14)Momentum oscillator 0–100 | 56.6 | 48.9 |
| Avg Volume (50D)Average daily shares traded | 47K | 444K |
Evenly matched — CRMLW and CRIS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | CRMLWCritical Metals C… | CRISCuris, Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
CRMLW leads in 2 of 6 categories (Valuation Metrics, Total Returns). CRIS leads in 1 (Profitability & Efficiency). 1 tied.
Best OverallCritical Metals Corp. (CRMLW)Leads 2 of 6 categories
Loading custom metrics...
CRMLW vs CRIS: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Which is the better long-term investment — CRMLW or CRIS?
Over the past 5 years, Critical Metals Corp.
(CRMLW) delivered a total return of +42. 3%, compared to -99. 7% for Curis, Inc. (CRIS). Over 10 years, the gap is even starker: CRMLW returned +42. 3% versus CRIS's -99. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
02Which is safer — CRMLW or CRIS?
By beta (market sensitivity over 5 years), Curis, Inc.
(CRIS) is the lower-risk stock at 1. 87β versus Critical Metals Corp. 's 2. 96β — meaning CRMLW is approximately 58% more volatile than CRIS relative to the S&P 500.
03Which is growing faster — CRMLW or CRIS?
On earnings-per-share growth, the picture is similar: Curis, Inc.
grew EPS 91. 6% year-over-year, compared to -154. 6% for Critical Metals Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
04Which has better profit margins — CRMLW or CRIS?
Critical Metals Corp.
(CRMLW) is the more profitable company, earning 0. 0% net margin versus -80. 3% for Curis, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRMLW leads at 0. 0% versus -348. 4% for CRIS. At the gross margin level — before operating expenses — CRIS leads at 99. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — CRMLW or CRIS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is CRMLW or CRIS better for a retirement portfolio?
For long-horizon retirement investors, Curis, Inc.
(CRIS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Critical Metals Corp. (CRMLW) carries a higher beta of 2. 96 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CRIS: -99. 7%, CRMLW: +42. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between CRMLW and CRIS?
These companies operate in different sectors (CRMLW (Basic Materials) and CRIS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.